Hoiyan Lam

A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2

Hanjun Zhao, Kelvin Kai‐Wang To, Kong-Hung Sze et al. · Nature Communications · 2020 · 112 citations · Full text

Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2

Hanjun Zhao, Kelvin Kai‐Wang To, Hoiyan Lam et al. · Nature Communications · 2021 · 59 citations · Full text

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant

Ka-Wa Khong, Danlei Liu, Ka‐Yi Leung et al. · Vaccines · 2022 · 42 citations · Full text

Immunology, Omicron Variant, Antibody Response +16

Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants

Hanjun Zhao, Xinjie Meng, Peng Zheng et al. · Emerging Microbes & Infections · 2022 · 25 citations · Full text

Fusion-inhibition Peptide, Viral Pathogenesis, Immunology +11

A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters

Hanjun Zhao, Kelvin Kai‐Wang To, Hoiyan Lam et al. · Cell Discovery · 2022 · 19 citations · Full text

Medicine, Viral Pathogenesis, Immunology +12